Trial Profile
Local Oestrogen Treatment in Postmenopausal Women Undergoing Pelvic Organ Prolapse Surgery (LOTUS) - Feasibility Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2023
Price :
$35
*
At a glance
- Drugs Estradiol (Primary)
- Indications Menopausal syndrome
- Focus Therapeutic Use
- Acronyms LOTUS
- 05 Nov 2015 Planned End Date changed from 28 Mar 2017 to 1 Jul 2017 as reported by United Kingdom Clinical Research Network record.
- 05 Nov 2015 Accrual to date is 34%, according to United Kingdom Clinical Research Network record.
- 05 Nov 2015 Accrual to date is 25%, according to United Kingdom Clinical Research Network record.